Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Propranolol
PROPANALOL · Avlocardyl · rac-Propanolol · 1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol · Reducor · Betalong · Avlocanol · 208-378-0

식별자 및 물리적 특성
| CAS No. | 13013-17-7 |
|---|---|
| 분자식 | C16H21NO2 |
| 평균 분자량 | 259.34 g/mol |
| 단동위원소 질량 | 259.15722891 g/mol |
| SMILES | CC(C)NCC(O)COc1cccc2ccccc12 |
| InChIKey | AQHHHDLHHXJYJD-UHFFFAOYSA-N |
| PubChem CID | 4946 |
| ChEMBL | CHEMBL27 |
| ChEBI | CHEBI:8499 |
| EC No. | 208-378-0 |
| DTXSID | DTXSID6023525 |
화학 및 물리적 성질
| XLogP | 3 |
|---|---|
| 극성 표면적 | 41.5 |
| 수소 결합 공여자 수 | 2 |
| 수소 결합 수용자 수 | 3 |
| 회전 가능 결합 수 | 6 |
| 무거운 원자 수 | 19 |
| 형식 전하 | 0 |
| 복잡도 | 257 |
| 물질 분류 | Other Uses -> Pharmaceuticals |
| 의약품 | Pharmaceuticals -> Antihypertensive drugsPharmaceuticals -> Used in Switzerland |
| LogP(분배 계수) | 3.483.09 |
| 용해도 | 0.0617 mg/L at 25 °CDMSO(약간 용해됨), 메탄올(약간 용해됨) |
| Human Drugs | Antidepressants -> Beta blockersBreast FeedingLactationMilk, HumanAntihypertensive AgentsAdrenergic Beta-AntagonistsAntiarrhythmicsEMA approved medicines: Human medicinePharmaceuticalsAntianginal medicines |
| 녹는점 | 96 °C163-164 °C |
| Physical Description | Solid |
| Ionization Efficiency | Positive3.752.7Agilent XCTElectrospray ionizationformic acid (5.3nM) |
| Dissociation Constants | 9.539.459.42 |
| Collision Cross Section | 162.5 Ų [M+H]+ [CCS Type: DTBuffer gas: N2Ionization: APCI+Dataset: TOXCASTSource Identifier: DTXSID3021198]161.5 Ų [M+H]+ [CCS Type: TWMethod: calibrated with polyalanine and drug standards]162.7 Ų [M+H]+ [CCS Type: TWMethod: Major Mix IMS/Tof Calibration Kit (Waters)]155.55 Ų [M+H-H2O]+ [CCS Type: TW |
| 끓는 점 | 402.6°C (rough estimate) |
| 밀도 | 1.0280 (rough estimate) |
| 굴절률 | 1.5500 (estimate) |
| 저장 조건 | -20°C Freezer, Under inert atmosphere |
| 물리적 상태 | 고체 |
| pKa(산도 계수) | 13.84±0.20(Predicted) |
| 색상 | 흰색에서 황백색까지 |
| 용해도 | 80.99mg/L(25℃) |
| InChI | InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3 |
| InChIKey | AQHHHDLHHXJYJD-UHFFFAOYSA-N |
| SMILES | C(NC(C)C)C(O)COC1=C2C(C=CC=C2)=CC=C1 |
| NIST | Propranolol(525-66-6) |
| EPA | 2-Propanol, 1-[(1-methylethyl)amino]-3-(1-naphthalenyloxy)- (525-66-6) |
화학적 성질
Colorless crystals.Soluble in water and alcohol; insoluble in benzene and ether.
안전 및 규제
| GHS 분류 | WarningH302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 2 reports by companies from 1 notifications to the ECHA C&L Inventory. |
|---|---|
| 규제 정보 | Status: Active Update: 13-09-2017 https://echa.europa.eu/registration-dossier/-/registered-dossier/20584Propranolol: Does not have an individual approval but may be used under an appropriate group standard |
| 기타 안전 정보 | IMAP assessments - 2-Propanol, 1-[(1-methylethyl)amino]-3-(1-naphthalenyloxy)-: Human health tier I assessment |
| 유해성 요약 | Allergic contact dermatitis reported in pharmaceutical workers[Kanerva, p. 1830] See Oxprenolol. |
| Hazard Classes and Categories | Acute Tox. 4 (100%) |
| Hepatotoxicity | Mild-to-moderate elevations in serum aminotransferase levels occur in less than 2% of patients on propranolol and are usually transient and asymptomatic, resolving even with continuation of therapy. Despite its widespread use, propranolol has not been convincingly linked to instances of clinically apparent liver injurythe few cases reported have generally occurred in patients who were receiving other well known hepatotoxic agents or were associated with elevations in serum enzymes only without jaundice. |
| 유해 작용 | Skin Sensitizer - An agent that can induce an allergic reaction in the skin.Common side effects of using propranolol include bradycardia, gastrointestinal issues, abdominal pain, nausea, erectile dysfunction, and wheezing/bronchospasms. Propranolol use can also cause drowsiness, fatigue, and cold extremities. Some extreme side effects to be aware of include allergic reactions, insulin resistance, and hallucinations. Prescribers need to explain and discuss all of the side effects before giving patients a prescription for propranolol. |
| 독성 요약 | Ingestion of greater than 1 g of propranolol in 24 hours can potentially be lethal and lead to profound bradycardia, bradyarrhythmia, hypotension, bronchospasm. |
| Drug Induced Liver Injury | Benchmark Dataset for the Liver Toxicity Knowledge Base (LTKB) |
용도
개요
Propranolol was responsible for sensitisation of workers in drug synthesis. In one case, epichlorhydrin was used for the production of both propranolol and oxprenolol.
용도
Cardiac depressant (anti-arrhythmic); anti-adrenergic (β-receptor).